About Basking Biosciences
Basking Biosciences is a company based in Columbus (United States) founded in 2019. Basking Biosciences has raised $89.8 million across 5 funding rounds from investors including The Ohio State University, HHS and RTW Investments. The company has 3 employees as of December 31, 2024. Basking Biosciences operates in a competitive market with competitors including Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma, Remedium Bio and 4TEEN4 Pharmaceuticals, among others.
- Headquarter Columbus, United States
- Employees 3 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Basking Biosciences, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$89.8 M (USD)
in 5 rounds
-
Latest Funding Round
$55 M (USD), Series C
Feb 01, 2024
-
Investors
The Ohio State University
& 10 more
-
Employee Count
3
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Basking Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of Basking Biosciences
Basking Biosciences has successfully raised a total of $89.8M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $55 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Basking Biosciences
Basking Biosciences has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include The Ohio State University, HHS and RTW Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked | |
|
Investment firm scaling software and technology companies from early to late stages.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Basking Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Basking Biosciences
Investment portfolio details for Basking Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Basking Biosciences
Detailed financials for Basking Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Basking Biosciences Comparisons
Peer comparison for Basking Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Basking Biosciences
Basking Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma, Remedium Bio and 4TEEN4 Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Immunotherapeutics are developed for ischemic stroke treatment using monoclonal antibodies.
|
|
| Locked | Locked | Locked |
Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury.
|
|
| Locked | Locked | Locked |
Drugs for haemorrhagic stroke and intracranial haemorrhage are developed.
|
|
| Locked | Locked | Locked |
Gene therapies for immune and age-related conditions are developed.
|
|
| Locked | Locked | Locked |
Therapeutics and diagnostics for cardiovascular diseases are developed.
|
Detailed competitors of Basking Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Basking Biosciences
Complete news archive for Basking Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Basking Biosciences
Basking Biosciences was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Basking Biosciences is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Rich Shea is the current CEO of Basking Biosciences.
Basking Biosciences is a funded company, having raised a total of $89.8M across 5 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Basking Biosciences is 3.
Basking Biosciences was founded in 2019 in Columbus, United States, as a biotechnology firm focused on therapeutics for ischemic stroke. Drug candidate BB-031, an RNA aptamer that inhibits von Willebrand Factor, has been shown to enable vessel recanalization. Additionally, BB-025, a sequence-specific reversal oligonucleotide, is provided to neutralize the effects of BB-031. Operations center on advancing these candidates through development stages.
Basking Biosciences's top competitors include Acticor Biotech, 4TEEN4 Pharmaceuticals and Remedy Pharmaceuticals.
Basking Biosciences has 11 investors. Key investors include The Ohio State University, HHS, RTW Investments, Arch Venture Partners, and Viva BioInnovator.